The role of bispecific antibodies in relapsed refractory multiple myeloma: a systematic review R Khanam, OS Ashruf, SHB Waqar, Z Shah, S Batool, R Mehreen, ... Antibodies 12 (2), 38, 2023 | 10 | 2023 |
Management of adverse reactions for BCMA-directed therapy in relapsed multiple myeloma: A focused review R Khanam, B Faiman, S Batool, MM Najmuddin, R Usman, K Kuriakose, ... Journal of Clinical Medicine 12 (17), 5539, 2023 | 6 | 2023 |
A Case Report of Baclofen-and Clozapine-Induced Dyskinesia: A Movement Disorder M Maliha, Z Roksana, P Dutta, MY Mamoon, MQ Islam Cureus 14 (5), 2022 | 1 | 2022 |
The Outcome of Cytotoxic-T-Lymphocytes and Brentuximab on Post Transplant Lymphoproliferative Disorder: A Systematic Review and Meta-Analysis R Khanam, Z Roksana, A Naeem, R Mehreen, MEU Rehman, Z Shah, ... Blood 140 (Supplement 1), 12127-12128, 2022 | | 2022 |
Management of Complications of BCMA-Directed Therapy in Relapsed Multiple Myeloma: A Focused Review R Khanam, S Batool, MM Najmuddin, R Usman, K Kuriakose, A Ahmed, ... Blood 140 (Supplement 1), 12494-12495, 2022 | | 2022 |
631P A meta-analysis of the outcome of post-transplant lymphoproliferative disorder in adult patients after hematopoietic stem cell transplant L Kantamneni, R Khanam, Z Shah, B Laek, M Ebad, Z Roksana, D Franco, ... Annals of Oncology 33, S831-S832, 2022 | | 2022 |
The Relationship Between Exacerbation of Pachymeningitis and Chemotherapy: A Case Report M Maliha, Z Roksana, SA Babli, K Chowdhury, D West Cureus 14 (6), 2022 | | 2022 |
The association between minimal residual disease status and survival outcomes in transplant-ineligible newly diagnosed multiple myeloma (TIE-NDMM) patients: Systematic review. Z Shah, I Khan, II Selene, SHB Waqar, R Khanam, Q Abid, N Tahir, ... Journal of Clinical Oncology 40 (16_suppl), e20009-e20009, 2022 | | 2022 |